Monthly Archives: October 2009
Assessing the Chances for the Next Wave of Obesity Drugs
By ANDREW POLLACK New York Times Published: October 16, 2009 How do the three new obesity drugs stack up? So far, investors — and some doctors — are most excited about Vivus’s drug, Qnexa. Patients taking the high dose of … Continue reading
No Clear Winner as Top Obesity Candidates Reveal Detailed Data
By Jennifer Boggs Investors – and prospective partners – hoping that detailed data emerging from this year’s Obesity Society meeting in Washington might shed more light on the three frontrunners in the weight loss drug race came away with some … Continue reading
What is Qnexa? Diet Pill
Qnexa™ is a therapeutic formula and dosing regimen which combines the active ingredients from two previously approved products which demonstrated weight loss properties: phentermine and topiramate. Qnexa simultaneously addresses appetite and satiety, the two main mechanisms that impact eating behavior … Continue reading
Positive Weight loss
Once you have made up your mind to lose weight, you should make that commitment and go into it with a positive attitude. We all know that losing weight can be quite a challenge. In fact, for some, it can … Continue reading